참고문헌
- Ministry for Health, Welfare and Family Affairs. Annual report of cancer incidence (2007), cancer prevalence (2007) and survival (1993-2007) in Korea, 2009.
- Statistics Korea. Annual report on the cause of death statistics in 2006, 2007.
- Mayer RJ. Gastrointestinal tract cancer. In: Fauci AS, Braunwald E, Kasper DL, et al, eds. Harrison's principles of internal medicine. Volume 1. 17th ed. New York: McGraw-Hill, 2008:573-578.
- Joint WHO/FAO Expert Consultation on Diet, Nutrition and the Prevention of Chronic Diseases. Diet, nutrition and the prevention of chronic diseases: Report of a Joint WHO/FAO Expert Consultation. WHO Technical Report Series 916. Geneva: World Health Organization, 2003.
- World Cancer Research Fund and American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research, 2007.
- Schoen RE, Tangen CM, Kuller LH, et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999;91:1147-1154. https://doi.org/10.1093/jnci/91.13.1147
- Kaaks R, Toniolo P, Akhmedkhanov A, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000;92:1592-1600. https://doi.org/10.1093/jnci/92.19.1592
- Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001;131:3109S-3120S.
- Frezza EE, Wachtel MS, Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut 2006;55:285-291. https://doi.org/10.1136/gut.2005.073163
- Wie EK, Ma J, Pallak MN, et al. A prospective study of C-peptide, insulin like growth factor-1, insulin like growth factor binding protein-1 and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2005;14:850-855. https://doi.org/10.1158/1055-9965.EPI-04-0661
- Yeon JE. Nonalcoholic fatty liver disease: pathogenesis and treatment. Korean J Med 2006;70:246-252.
- Yun JW, Cho YK. Clinical impact of non-alcoholic fatty liver disease on other medical disease. Korean J Med 2009;76:25-29.
- Park JH. Insulin resistance in non-alcoholic fatty liver disease. Korean J Hepatol 2006;12:16-30.
- Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231. https://doi.org/10.1056/NEJMra011775
- Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002;122:1649-1657. https://doi.org/10.1053/gast.2002.33573
- Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003;37:1202-1219. https://doi.org/10.1053/jhep.2003.50193
- The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003;58(suppl):3S-43S.
- Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 2005;37:570-578. https://doi.org/10.1055/s-2005-861352
- O'Brien MJ, Winawer SJ, Zauber AG, et al. The national polyp study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroentrology 1990;98:371-379.
- Scatarige JC, Scott WW, Donovan PJ, Siegelman SS, Sanders RC. Fatty infiltration of the liver: ultrasonographic and computed tomographic correlation. J Ultrasound Med 1984;3:9-14.
- Jackman RJ, Mayo CW. The adenoma-carcinoma sequence in cancer of the colon. Surg Gynecol Obstet 1951;93:327-330.
- Rider JA, Kirsner JB, Moeller HC, Palmer WL. Polyps of the colon and rectum, their incidence and relationship to carcinoma. Am J Med 1954;16:555-564. https://doi.org/10.1016/0002-9343(54)90372-1
- Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M; Italian Multicentre Study Group. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001;48:812-815. https://doi.org/10.1136/gut.48.6.812
- Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The national polyp study workgroup. N Engl J Med 1993;329:1977-1981. https://doi.org/10.1056/NEJM199312303292701
- Sato Y, Nozaki R, Yamada K, Takano M, Haruma K. Relation between obesity and adenomatous polyps of the large bowel. Dig Endosc 2009;21:154-157. https://doi.org/10.1111/j.1443-1661.2009.00877.x
- Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-438.
- Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995;22:1714-1719. https://doi.org/10.1002/hep.1840220616
- Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419. https://doi.org/10.1016/S0016-5085(99)70506-8
- Pessayre D, Berson A, Fromenty B, Mansouri A. Mitochondria in steatohepatitis. Semin Liver Dis 2001;21:57-69.
- Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparision of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991;43:26-31. https://doi.org/10.1016/S0009-9260(05)80350-2
- Hultcrantz R, Gabrielsson N. Patients with persistent elevation of aminotransferases: investigation with ultrasonography, radionuclide imaging and liver biopsy. J Intern Med 1993;233:7-12. https://doi.org/10.1111/j.1365-2796.1993.tb00640.x
- Park SH, Jeon WK, Kim SH, et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006;21:138-143. https://doi.org/10.1111/j.1440-1746.2005.04086.x
- Lee SY, Kim SK, Kwon CI, et al. Clinical characteristics of health screen examinees with nonalcoholic fatty liver and normal liver function test. Korean J Gastroenterol 2008;52:161-170.
- Ko ES, Shin JH, Kang EY, Hwang YN, Seo AR, Song SW. Relationship between non-alcoholic fatty liver disease and metabolic syndrome in examiners of a health promotion center in Kyeong-ki do. Korean J Obes 2008;17:37-44.
- Yamaji Y, Okamoto M, Yoshida H, et al. The effect of body weight reduction on the incidence of colorectal adenoma. Am J Gastroenterol 2008;103:2061-2067. https://doi.org/10.1111/j.1572-0241.2008.01936.x
- Jacobs ET, Ahnen DJ, Ashbeck EL, et al. Association between body mass index and colorectal nesoplasia at follow-up colonoscopy: a pooling study. Am J Epidemiol 2009;169:657-666. https://doi.org/10.1093/aje/kwn401
- Lee HL, Son BK, Lee OY, et al. Abdominal obesity, insulin resistance, and the risk of colonic adenoma. Korean J Gastroenterol 2007;49:147-151.
- Kim JH, Lim YJ, Kim YH, et al. Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev 2007;16:1543-1546. https://doi.org/10.1158/1055-9965.EPI-07-0199
- Davidow AL, Neugut AI, Jacobson JS, et al. Recurrent adenomatous polyps and body mass index. Cancer Epidemiol Biomarkers Prev 1996;5:313-315.
- Chung YW, Han DS, Park YK, et al. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Dig Liver Dis 2006;38:668-672. https://doi.org/10.1016/j.dld.2006.05.014
- Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity and risk for colon cancer and adenoma in men. Ann Intern Med 1995;122:327-334. https://doi.org/10.7326/0003-4819-122-5-199503010-00002
- Kim MC, Kim DH, Jeong TH. Risk factors of colorectal polyps in Korean adults. J Korean Acad Farm Med 2002;23:890-896.
- Ji JH, Park BJ, Park YS, et al. Clinicopathlologic study of colorectal polyps and obesity in Korean adults. Korean J Gastroenterol 2007;49:10-16.
- Giorgino F, Laviola L, Eriksson JW. Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol Scand 2005;183:13-30. https://doi.org/10.1111/j.1365-201X.2004.01385.x
- Schoen RE. Surveillance after positive and negative colonoscopy examinations: issues, yields, and use. Am J Gastroenterol 2003;98:1237-1246. https://doi.org/10.1111/j.1572-0241.2003.07492.x
- Friis-Liby I, Aldenborg F, Jerlstad P, Rundstrom K, Bjornsson E. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease. Scand J Gastroenterol 2004;39:864-869. https://doi.org/10.1080/00365520410006431
- Fan JG, Li F, Cai XB, Peng YD, Ao QH, Gao Y. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. J Gastroenterol Hepatol 2007;22:1086-1091. https://doi.org/10.1111/j.1440-1746.2006.04781.x
- Shibata M, Kihara Y, Taguchi M, Tashiro M, Otsuki M. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 2007;30:2940-2944. https://doi.org/10.2337/dc07-0792